🇺🇸 FDA
Patent

US 11208655

Functionally-modified oligonucleotides and subunits thereof

granted A61PA61P31/04A61P31/12

Quick answer

US patent 11208655 (Functionally-modified oligonucleotides and subunits thereof) held by Sarepta Therapeutics, Inc. expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P31/04, A61P31/12, A61P31/16